Advocacy Epilepsy Pharmaceutical Programs 
Cannabis Law Report
DECEMBER 3, 2021
.–(BUSINESS WIRE)– $MRNS #MarinusPharma — Marinus Pharmaceuticals, Inc. Chief Executive Officer of Marinus Pharmaceuticals. “We Phase 2, Placebo-Controlled Clinical Study of Oral Ganaxolone in PCDH19-Clustering Epilepsy (the Violet Study). About Marinus Pharmaceuticals. Marinus Pharmaceuticals, Inc.
MMJ Recs
NOVEMBER 17, 2023
The community impact is visible in several key areas: Healthcare Advancements MMJ has expanded the range of treatment options available to patients, offering an alternative to conventional pharmaceuticals. MMJ is known for its efficacy in treating various medical issues, including chronic pain, epilepsy, multiple sclerosis, and more.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Veriheal
FEBRUARY 21, 2023
Opioid Abuse and Drug Overdose Deaths Are Higher in States With Restrictive MMJ Policies Despite ongoing political debates about the limitations of medical marijuana programs, a 2019 study published in the Journal of Patient-Centered Research and Reviews provided further evidence of how MMJ-restrictive states inadvertently impact their patients.
MMJ Recs
FEBRUARY 3, 2024
Pennsylvania Medical Cannabis Program and Philadelphia Marijuana Dispensaries The Pennsylvania Medical Cannabis Program serves as the foundation for medical marijuana accessibility in Philadelphia. This can lead to a decreased reliance on pharmaceuticals that may adversely affect patients’ health and overall lifestyle.
NORML
AUGUST 26, 2019
So, it shouldn’t be a huge surprise that Virginia didn’t launch a medical marijuana program until 2015, nearly two decades after California. And it took extensive, concerted efforts from marijuana law reform organizations like NORML to negotiate with Virginia’s Republican Party to get the program finally running.
Veriheal
AUGUST 31, 2020
Program between St. Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. She is entering the 8-year Dual Admit B.S./M.D. Bonaventure University and George Washington University School of Medicine. .
Cannabis Law Report
JUNE 26, 2019
For those of you in the dark about Florida’s Medical Marijuana Program, I will be lighting up the dim corners of Florida: The Nation’s Fastest-Growing Medical Marijuana Market , according to The Miami New Times on May 2, 2019. Lighting Up Florida’s Medical Marijuana PEOPLE: The Front Lines. Cameron Vance, Ph.D. Eric Stevens.
Expert insights. Personalized for you.
52 
Let's personalize your content